M54 Individualizing Management with Insulin Pumps

Program: Meet-the-Professor Sessions
Clinical Session
Monday, April 4, 2016: 9:00 AM-9:45 AM
Room 107 (BCEC)
Speaker:
Anthony L. McCall, MD, PhD, University of Virginia Health System, Charlottesville, VA

Disclosures:
ALM: Clinical Researcher, to UVA research contract for ELIXA trial, Clinical Researcher, Lilly USA, LLC, Consultant, Pfizer, Inc..

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire